id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-S-0024-0493,FDA,FDA-2013-S-0024,Highland Laboratories (Good Niacin) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:50:53Z,,0,0,09000064819919ad
FDA-2013-S-0024-0485,FDA,FDA-2013-S-0024,Highland Laboratories (Liquid Quercetin Nettle) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:16:03Z,,0,0,0900006481991981
FDA-2013-S-0024-0501,FDA,FDA-2013-S-0024,Highland Laboratories (Nice Bones) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T16:16:43Z,,0,0,09000064819919ae
FDA-2013-S-0024-0492,FDA,FDA-2013-S-0024,Highland Laboratories (B12 Liquid) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:47:01Z,,0,0,09000064819919a5
FDA-2013-S-0024-0495,FDA,FDA-2013-S-0024,Highland Laboratories (One Good Multi) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:56:31Z,,0,0,09000064819919a7
FDA-2014-V-2320-0001,FDA,FDA-2014-V-2320,Acknowledgement Letter From FDA DDM to Extensive Music Sweden AB,Other,Acknowledgement Letter/Receipt,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T12:37:14Z,,0,0,090000648199b074
FDA-2014-D-2065-0002,FDA,FDA-2014-D-2065,Radiation Biodosimetry Devices Draft Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2024-11-12T05:31:58Z,,1,0,090000648199accc
FDA-2013-S-0024-0503,FDA,FDA-2013-S-0024,Highland Laboratories (Raspberry Ketones) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T16:22:19Z,,0,0,09000064819919b0
FDA-2013-S-0024-0479,FDA,FDA-2013-S-0024,Highland Laboratories - Cold Facts + Vitamin D - Supports healthy immune function,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,,,2017-06-12T20:55:53Z,,0,0,0900006481990c8e
FDA-2013-S-0024-0483,FDA,FDA-2013-S-0024,Highland Laboratories (Quercetin Nettle) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:11:42Z,,0,0,090000648199197f
FDA-2013-S-0024-0489,FDA,FDA-2013-S-0024,Highland Laboratories (Immun-D) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:33:13Z,,0,0,090000648199198f
FDA-2013-S-0024-0488,FDA,FDA-2013-S-0024,Highland Laboratories (Sweet Sleep) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:30:22Z,,0,0,0900006481991984
FDA-2013-S-0024-0482,FDA,FDA-2013-S-0024,Highland Laboratories (Eye Factors) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:09:46Z,,0,0,090000648199197e
FDA-2013-S-0024-0499,FDA,FDA-2013-S-0024,Highland Laboratories (Good Fizzy Mins) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T16:07:15Z,,0,0,09000064819919ab
FDA-2013-S-0024-0490,FDA,FDA-2013-S-0024,Highland Laboratories (Good Vitamin D) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:37:24Z,,0,0,09000064819919a3
FDA-2013-S-0024-0487,FDA,FDA-2013-S-0024,Highland Laboratories (Everyday Liquid Sunshine) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:22:50Z,,0,0,0900006481991983
FDA-2013-S-0024-0500,FDA,FDA-2013-S-0024,Highland Laboratories (Good Osteo) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T16:10:20Z,,0,0,09000064819919ac
FDA-2013-S-0024-0481,FDA,FDA-2013-S-0024,Highland Laboratories (Estro-Good) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:05:45Z,,0,0,090000648199197d
FDA-2013-S-0024-0498,FDA,FDA-2013-S-0024,Highland Laboratories (Womens 50+ Multi) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T16:05:12Z,,0,0,09000064819919aa
FDA-2014-N-1484-0001,FDA,FDA-2014-N-1484,Revisions to Exceptions Applicable to Certain Human Cells Tissues and Cellular and Tissue-Based Products,Proposed Rule,Amendment,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,2015-04-01T03:59:59Z,2015-04-01T02:01:23Z,2014-30528,0,0,090000648199bdf0
FDA-2013-S-0024-0480,FDA,FDA-2013-S-0024,Highland Laboratories (D-Tox) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:02:22Z,,0,0,090000648199197c
FDA-2014-D-2254-0001,FDA,FDA-2014-D-2254,The Drug Supply Chain Security Act Implementation Product Tracing Requirements Compliance Policy Guidance for Industry Availability,Notice,Notice of Availability,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2024-11-12T05:33:45Z,2014-30608,1,0,090000648199bfdc
FDA-2013-S-0024-0497,FDA,FDA-2013-S-0024,Highland Laboratories (Mens 50+ Multi) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T16:02:12Z,,0,0,09000064819919a9
FDA-2013-S-0024-0484,FDA,FDA-2013-S-0024,Highland Laboratories (PARA Response) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:13:47Z,,0,0,0900006481991980
FDA-2013-S-0024-0486,FDA,FDA-2013-S-0024,Highland Laboratories (Water Away) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:20:58Z,,0,0,0900006481991982
FDA-2013-S-0024-0491,FDA,FDA-2013-S-0024,Highland Laboratories (Triple B12 Dots) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:39:03Z,,0,0,09000064819919a4
FDA-2013-S-0024-0494,FDA,FDA-2013-S-0024,Highland Laboratories (Good C) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:53:27Z,,0,0,09000064819919a6
FDA-2013-S-0024-0496,FDA,FDA-2013-S-0024,Highland Laboratories (Simply 4 Energy) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T15:59:31Z,,0,0,09000064819919a8
FDA-2014-V-2320-0002,FDA,FDA-2014-V-2320,Variance Application Request from Extensive Music Sweden AB,Other,Application for Variance (VAR),2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T12:37:28Z,,0,0,090000648199ab9c
FDA-2013-S-0024-0502,FDA,FDA-2013-S-0024,Highland Laboratories (Strontium Bone Power) - Letter,Other,30 Day Structured Function Claim,2014-12-31T05:00:00Z,2014,12,2014-12-31T05:00:00Z,,2014-12-31T16:18:59Z,,0,0,09000064819919af
FDA-2014-N-1936-0002,FDA,FDA-2014-N-1936,Electronic Cigarettes and the Public Health Public Workshop,Notice,Meeting,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2015-03-04T12:21:12Z,2014-30450,0,0,0900006481999bbf
FDA-2014-V-2309-0001,FDA,FDA-2014-V-2309,Variance Application Request from Carestream Health Inc,Other,Application for Variance (VAR),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T17:35:53Z,,0,0,0900006481997959
FDA-2014-V-1705-0003,FDA,FDA-2014-V-1705,TECHNIC SOUNDZ ENTERTAINMENT Variance Approval,Other,Approval for Variance (VRA),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T18:36:15Z,,0,0,090000648199a915
FDA-2014-V-2309-0002,FDA,FDA-2014-V-2309,Acknowledgement Letter from FDA DDM to Caresteam Health Inc,Other,Acknowledgement Letter/Receipt,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T17:36:02Z,,0,0,090000648199a273
FDA-2007-D-0369-0310,FDA,FDA-2007-D-0369,Draft and Revised Draft Guidances for Industry Describing Product Specific Bioequivalence Recommendations Availability,Notice,Notice of Availability,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,2015-03-03T04:59:59Z,2024-11-12T05:29:27Z,2014-30514,1,0,0900006481999bc7
FDA-2014-V-2316-0001,FDA,FDA-2014-V-2316,Variance Application Request from Richard Astley,Other,Application for Variance (VAR),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T20:39:16Z,,0,0,090000648199a98d
FDA-2014-V-2308-0002,FDA,FDA-2014-V-2308,Acknowledgement Letter from FDA DDM to Carestream Health Inc,Other,Acknowledgement Letter/Receipt,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T17:05:52Z,,0,0,09000064819990fd
FDA-2006-N-0515-0091,FDA,FDA-2006-N-0515,Reference 4 Evaluation of How Best to Communicate with Healthcare Providers about the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women A Mental Models Research Report Final Report re Ref2 Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467),Supporting & Related Material,Background Material,2014-12-30T05:00:00Z,2014,12,,,2014-12-30T18:22:18Z,,0,0,090000648199a463
FDA-2014-V-2319-0002,FDA,FDA-2014-V-2319,Acknowledgement Letter from FDA DDM to Wibs,Other,Acknowledgement Letter/Receipt,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T20:44:10Z,,0,0,090000648199ab99
FDA-2014-V-2308-0001,FDA,FDA-2014-V-2308,Variance Application Request from Carestream Health Inc,Other,Application for Variance (VAR),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T17:05:31Z,,0,0,0900006481997957
FDA-2014-N-0797-0002,FDA,FDA-2014-N-0797,"Agency Information Collection Activities; Submission for Office of Management and Budget Review Comment Request Guidance Medical 
Device ISO 13485 2003 Voluntary Audit Report Submission Pilot Program",Notice,30 Day Proposed Information Collection,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,2015-01-30T04:59:59Z,2014-12-30T17:02:11Z,2014-30513,0,0,0900006481999c8a
FDA-2014-N-1027-0003,FDA,FDA-2014-N-1027,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval Infant Formula Recall Regulations,Notice,Notice of Approval,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T17:09:20Z,2014-30461,0,0,0900006481999d89
FDA-2014-D-2065-0001,FDA,FDA-2014-D-2065,Radiation Biodosimetry Devices Draft Guidance for Industry and Food and Drug Administration Staff Availability,Notice,Notice of Availability,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,2015-03-31T03:59:59Z,2024-11-12T05:30:49Z,2014-30453,1,0,09000064819999f5
FDA-2014-V-2319-0001,FDA,FDA-2014-V-2319,Variance Application Request  from Wibs,Other,Application for Variance (VAR),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T20:44:01Z,,0,0,090000648199ae5c
FDA-2014-E-2321-0002,FDA,FDA-2014-E-2321,Patent Extension Application from Hyperion on Behalf of Brusilow Enterprises LLC,Other,Application,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2015-01-07T22:00:23Z,,0,0,090000648199acc9
FDA-2011-N-0920-1938,FDA,FDA-2011-N-0920,Supplement from the California Dried Plum Board,Other,Supplement (SUP),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T15:48:53Z,,0,0,090000648197c7db
FDA-2014-V-2315-0001,FDA,FDA-2014-V-2315,Variance Application Request from 727 BUILDING,Other,Application for Variance (VAR),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T20:36:34Z,,0,0,090000648199a446
FDA-2014-V-2315-0002,FDA,FDA-2014-V-2315,Acknowledgement Letter from FDA DDM to 727 BUILDING,Other,Acknowledgement Letter/Receipt,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T20:36:41Z,,0,0,090000648199a992
FDA-2014-P-1065-0007,FDA,FDA-2014-P-1065,Citizen Petition Approval Response Letter from FDA CDER to Zydus Pharmaceuticals Inc,Other,Approval,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T17:46:49Z,,0,0,0900006481999f0d
FDA-2014-P-0646-0002,FDA,FDA-2014-P-0646,Letter from Kamat Pharmatech to FDA/DDM,Other,Letter(s),2014-12-30T05:00:00Z,2014,12,,,2015-01-08T15:29:29Z,,0,0,090000648199a275
FDA-2011-N-0921-1481,FDA,FDA-2011-N-0921,Supplement from the California Dried Plum Board,Other,Supplement (SUP),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T15:19:24Z,,0,0,090000648197cb43
FDA-2014-V-2316-0002,FDA,FDA-2014-V-2316,Acknowledgement Letter from FDA DDM to Richard Astley,Other,Acknowledgement Letter/Receipt,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T20:39:33Z,,0,0,090000648199a7d3
FDA-1989-V-0020-0004,FDA,FDA-1989-V-0020,"Letter from FDA CDRH to Faith's Sound & Light, Inc.",Other,Approval for Variance (VRA),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2024-03-01T13:34:37Z,,0,0,090000648199a98f
FDA-2014-N-0998-0002,FDA,FDA-2014-N-0998,"Agency Information Collection Activities Submission for Office of Management and Budget Review Comment Request Regulations for In 
Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring",Notice,30 Day Proposed Information Collection,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,2015-01-30T04:59:59Z,2015-03-08T19:42:01Z,2014-30452,0,0,0900006481999bc3
FDA-2013-P-1552-0001,FDA,FDA-2013-P-1552,Citizen Petition from Hearing Industries Association (HIA),Other,Citizen Petition,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2016-03-14T13:42:23Z,,0,0,09000064814c28cb
FDA-2014-E-2321-0001,FDA,FDA-2014-E-2321,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T22:10:34Z,,0,0,090000648199ab9e
FDA-2014-V-2318-0001,FDA,FDA-2014-V-2318,Variance Application Request from B&L Motorsports,Other,Application for Variance (VAR),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T20:41:35Z,,0,0,090000648199ad0b
FDA-2014-P-0646-0003,FDA,FDA-2014-P-0646,Letter from Kamat Pharmatech to FDA/DDM,Other,Letter(s),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2016-09-15T19:10:05Z,,0,0,090000648199a464
FDA-2014-N-0001-0104,FDA,FDA-2014-N-0001,Science Board to the Food and Drug Administration Notice of Meeting,Notice,Public Meetings,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T15:34:56Z,2014-30516,0,0,0900006481999ad1
FDA-2013-P-1552-0002,FDA,FDA-2013-P-1552,Letter from FDA CDRH to Hearing Industries Association,Other,Letter(s),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2016-03-14T13:43:29Z,,0,0,09000064814ac78b
FDA-2011-N-0672-0003,FDA,FDA-2011-N-0672,Agency Information Collection Activities Proposed Collection Comment Request Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices,Notice,60 Day Proposed Information Collection,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,2015-03-03T04:59:59Z,2015-04-08T13:06:22Z,2014-30511,0,0,0900006481999b05
FDA-2014-V-2318-0002,FDA,FDA-2014-V-2318,Acknowledgement Letter from FDA DDM to B&L Motorsports,Other,Acknowledgement Letter/Receipt,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T20:41:48Z,,0,0,090000648199ab97
FDA-2014-N-0001-0105,FDA,FDA-2014-N-0001,Guidance: Advisory Committees; Filing of Closed Meeting Reports,Notice,Report Submissions,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T16:05:56Z,2014-30460,0,0,0900006481999b53
FDA-2011-E-0117-0008,FDA,FDA-2011-E-0117,"Response Letter from FDA CDER to Boehringer Ingelheim Pharma GmbH & Co. KG, Hogan Lovells US LLP",Other,Answer,2014-12-29T05:00:00Z,2014,12,2014-12-29T05:00:00Z,,2014-12-29T18:32:45Z,,0,0,0900006481996e52
FDA-2014-P-2301-0002,FDA,FDA-2014-P-2301,"Acknowledgement Letter From FDA DDM to Probiomed S.A. de C.V., Mexico",Other,Acknowledgement Letter/Receipt,2014-12-29T05:00:00Z,2014,12,2014-12-29T05:00:00Z,,2014-12-29T20:01:03Z,,0,0,0900006481996c83
FDA-1984-P-0032-0001,FDA,FDA-1984-P-0032,Citizen Petition from Rowell Laboratories,Other,Citizen Petition,2014-12-29T05:00:00Z,2014,12,2014-12-29T05:00:00Z,,2022-05-26T17:37:09Z,,0,0,09000064805a820b
FDA-1984-P-0032-0003,FDA,FDA-1984-P-0032,Letter from FDA to Rowell Laboratories re Confidentiality,Other,Letter(s),2014-12-29T05:00:00Z,2014,12,2014-12-29T05:00:00Z,,2022-05-27T18:14:44Z,,0,0,09000064805a820d
FDA-2014-P-2301-0001,FDA,FDA-2014-P-2301,Citizen Petition From Probiomed S.A. de C.V. Mexico,Other,Citizen Petition,2014-12-29T05:00:00Z,2014,12,2014-12-29T05:00:00Z,,2024-11-12T05:31:36Z,,1,0,0900006481991a9e
FDA-1984-P-0032-0002,FDA,FDA-1984-P-0032,Acknowledgement Letter to Rowell Laboratories,Other,Acknowledgement Letter/Receipt,2014-12-29T05:00:00Z,2014,12,2014-12-29T05:00:00Z,,2022-05-27T18:13:09Z,,0,0,09000064819975cd
FDA-2014-N-2214-0001,FDA,FDA-2014-N-2214,Next Generation Sequencing Diagnostic Tests Public Workshop Request for Comments,Notice,Request for Comments,2014-12-29T05:00:00Z,2014,12,2014-12-29T05:00:00Z,2015-03-21T03:59:59Z,2015-03-22T02:01:51Z,2014-30308,0,0,0900006481995ff6
FDA-1984-P-0032-0004,FDA,FDA-1984-P-0032,Petition Denial Letter from FDA to Rowell Laboratories,Other,Denial,2014-12-29T05:00:00Z,2014,12,2014-12-29T05:00:00Z,,2022-05-27T18:15:22Z,,0,0,09000064805a820e
FDA-2014-N-2104-0001,FDA,FDA-2014-N-2104,Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection of Ebola Zaire Virus; Availability,Notice,Notice of Availability,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,,2014-12-24T19:05:36Z,2014-30108,0,0,09000064819914d1
FDA-2014-D-1856-0005,FDA,FDA-2014-D-1856,"Reference 2 Brown et al., Basic Science Review on Adipose Tissue for Clinicians re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002",Supporting & Related Material,Background Material,2014-12-24T05:00:00Z,2014,12,,,2015-01-02T15:19:45Z,,0,0,0900006481991c17
FDA-2014-P-0919-0004,FDA,FDA-2014-P-0919,Interim Response from CDRH to Daniel Schumaier,Other,Response(s),2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,,2014-12-24T18:59:53Z,,0,0,0900006481991a9b
FDA-2013-S-0024-0472,FDA,FDA-2013-S-0024,Pharmavite - Maximum Strength D3 1000 IU - Vitamin D helps support heart health,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,,,2017-06-12T20:36:49Z,,0,0,090000648199107a
FDA-2013-S-0024-0473,FDA,FDA-2013-S-0024,NOW Foods - Vitamin K2 - Supports bone health,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,,,2017-06-12T20:48:29Z,,0,0,090000648199107b
FDA-2013-S-0024-0478,FDA,FDA-2013-S-0024,Highland Laboratories (Slim-Zymes) - Letter,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,,2014-12-24T15:36:02Z,,0,0,0900006481990c88
FDA-2010-N-0155-0207,FDA,FDA-2010-N-0155,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Veterinary Feed
Directive",Notice,30 Day Proposed Information Collection,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,2015-01-24T04:59:59Z,2015-01-08T03:01:55Z,2014-30157,0,0,090000648199147f
FDA-2014-N-2185-0002,FDA,FDA-2014-N-2185,"Letter from FDA CFSAN Office of Nutritional Products, Labeling, and Dietary Supplements to Unilever North America, December 23, 2014",Supporting & Related Material,Reference (internal unless indicated),2014-12-24T05:00:00Z,2014,12,,,2014-12-24T21:40:28Z,,0,0,090000648199247d
FDA-2014-D-1856-0002,FDA,FDA-2014-D-1856,"Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
From Adipose Tissue: Regulatory Considerations; Draft Guidance for
Industry",Other,Guidance,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,,2024-11-12T05:31:43Z,,1,0,0900006481991c12
FDA-2013-S-0024-0470,FDA,FDA-2013-S-0024,Herb Pharm - Liquid Herbal Extract Soothing throat spray - Supports healthy function of the immune system,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,,,2017-06-13T18:39:58Z,,0,0,0900006481991078
FDA-2013-S-0024-0474,FDA,FDA-2013-S-0024,Highland Laboratories - Folic Acid and B12 original formula - Supports healthy RNA and DNA,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,,,2017-06-12T20:53:17Z,,0,0,0900006481991081
FDA-2009-F-0303-0031,FDA,FDA-2009-F-0303,Food Additives Permitted for Direct Addition to Food for Human Consumption: Advantame,Rule,Final Rule,2014-12-24T05:00:00Z,2014,12,,,2014-12-24T18:21:53Z,2014-30144,0,0,0900006481991334
FDA-2014-D-1856-0004,FDA,FDA-2014-D-1856,"Reference 1 Chapter 6 Adipose Tissue re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002",Supporting & Related Material,Background Material,2014-12-24T05:00:00Z,2014,12,,,2015-01-02T15:19:44Z,,0,0,0900006481991c15
FDA-2014-D-1856-0001,FDA,FDA-2014-D-1856,"Human Cells, Tissues, and Cellular and Tissue-Based Products From Adipose Tissue: Regulatory Considerations; Draft Guidance for Industry; Availability",Proposed Rule,Request for Comment,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,2015-02-24T04:59:59Z,2015-02-24T03:13:21Z,2014-30142,0,0,09000064819914d3
FDA-2013-S-0024-0471,FDA,FDA-2013-S-0024,Solstice Medicine Company - Tang Sheng Hair Nourishment Capsules Herbal Dietary Supplement - Supports the health of the hair and scalp,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,,,2017-06-13T18:42:52Z,,0,0,0900006481991079
FDA-2014-D-1461-0003,FDA,FDA-2014-D-1461,"Rare Pediatric Disease Priority Review Vouchers; Extension of Comment
Period",Notice,Extension of Comment Period,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,2015-02-17T04:59:59Z,2015-03-25T02:02:24Z,2014-30154,0,0,09000064819914d2
FDA-2013-S-0024-0469,FDA,FDA-2013-S-0024,Bayer HealthCare Consumer Care (Bayer) - One A Day® Men's Health Formula Multivitamin/Multimineral Supplement - Heart Health,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,,,2017-06-13T18:32:17Z,,0,0,090000648199019e
FDA-2014-D-1856-0003,FDA,FDA-2014-D-1856,"Reference List re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002",Supporting & Related Material,Background Material,2014-12-24T05:00:00Z,2014,12,,,2014-12-24T20:22:25Z,,0,0,0900006481991c14
FDA-2013-S-0024-0477,FDA,FDA-2013-S-0024,Highland Laboratories (Good Green Coffee Bean with Garcinia) - Letter,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,,2014-12-24T15:33:28Z,,0,0,0900006481990c87
FDA-2013-N-1529-0018,FDA,FDA-2013-N-1529,Medical Device Classification Procedures: Reclassification Petition: Content and Form; Technical Amendment,Rule,Final Rule,2014-12-24T05:00:00Z,2014,12,,,2014-12-24T17:15:31Z,2014-30141,0,0,090000648199128e
FDA-2014-N-0001-0103,FDA,FDA-2014-N-0001,"General and Plastic Surgery Devices Panel of the Medical Devices Advisory
Committee; Notice of Meeting",Notice,Public Meetings,2014-12-24T05:00:00Z,2014,12,,,2014-12-24T17:20:01Z,2014-30149,0,0,0900006481991291
FDA-2014-N-2185-0001,FDA,FDA-2014-N-2185,"Letter from the Institute of Medicine of the National Academies to FDA CFSAN, May 5, 2004",Supporting & Related Material,Reference (internal unless indicated),2014-12-24T05:00:00Z,2014,12,,,2014-12-24T21:40:21Z,,0,0,090000648199247c
FDA-2013-S-0024-0475,FDA,FDA-2013-S-0024,Highland Laboratories (Folic Acid and B12 Methylcobalamin) - Letter,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,,2014-12-24T15:24:08Z,,0,0,0900006481990c85
FDA-2013-S-0024-0476,FDA,FDA-2013-S-0024,Highland Laboratories (Good Minerals) - Letter,Other,30 Day Structured Function Claim,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,,2014-12-24T15:27:12Z,,0,0,0900006481990c86
FDA-2007-D-0369-0309,FDA,FDA-2007-D-0369,"Bioequivalence Recommendations for Methylphenidate Hydrochloride
Extended-Release Oral Suspension; Draft Guidance for Industry;
Availability",Notice,Notice of Availability,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,2015-02-24T04:59:59Z,2015-02-24T03:14:02Z,2014-30109,0,0,09000064819910d4
FDA-2014-V-2274-0002,FDA,FDA-2014-V-2274,Acknowledgement Letter from FDA DDM to Kenjix,Other,Acknowledgement Letter/Receipt,2014-12-23T05:00:00Z,2014,12,2014-12-23T05:00:00Z,,2014-12-23T15:16:56Z,,0,0,090000648198f225
FDA-2014-P-2276-0004,FDA,FDA-2014-P-2276,"Exhibit 3 Citizen Petition From Alan Laboratories, Inc.",Supporting & Related Material,Background Material,2014-12-23T05:00:00Z,2014,12,,,2014-12-23T14:22:49Z,,0,0,090000648198e718
FDA-2014-D-1696-0001,FDA,FDA-2014-D-1696,Minimal Manipulation of Human Cells Tissues and Cellular and Tissue Based Products Draft Guidance for Industry and Food and Drug Administration Staff Availability,Notice,Notice of Availability,2014-12-23T05:00:00Z,2014,12,2014-12-23T05:00:00Z,2015-02-24T04:59:59Z,2015-02-25T03:05:07Z,2014-30011,0,0,090000648198eace
FDA-2014-P-2276-0002,FDA,FDA-2014-P-2276,"Exhibit 1 Citizen Petition From Alan Laboratories, Inc.",Supporting & Related Material,Background Material,2014-12-23T05:00:00Z,2014,12,,,2014-12-23T14:22:26Z,,0,0,090000648198e714